Chimeric Antigen Receptor (CARs) for Thymidine Kinase 1 (TK1): A novel immunotherapy approach to fight cancer.
Description
We have found the expression of Thymidine Kinase 1 (TK1) on the cell membrane of multiple cancer cell lines. We propose TK1 as a novel potential target for immune cell recognition in different cancer cell lines. Our research explores the use of these new targets in Chimeric antigen receptor (CAR) T-cell therapy.
This paper has been withdrawn.
Chimeric Antigen Receptor (CARs) for Thymidine Kinase 1 (TK1): A novel immunotherapy approach to fight cancer.
We have found the expression of Thymidine Kinase 1 (TK1) on the cell membrane of multiple cancer cell lines. We propose TK1 as a novel potential target for immune cell recognition in different cancer cell lines. Our research explores the use of these new targets in Chimeric antigen receptor (CAR) T-cell therapy.